The phosphorylation status of Sfi1, a structural component of the yeast centrosome, governs the centrosome duplication cycle, raising the possibility that licensing of centrosome duplication occurs by modulating Sfi1, which potentially acts as a template for a new centrosome.
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The centrosome is a fascinating single copy organelle present in almost all higher eukaryotic cells. It acts as the major microtubule organizing centre (MTOC) as well as a platform for various cell proliferation and differentiation regulators [1, 2] . Apart from the centrosome's divergent fundamental roles, its mode of duplication has intrigued us for decades -it occurs strictly once per cell cycle in a semi-conservative manner. Failure to keep precise control over centrosome number is often associated with malignant tumor cells [3, 4] . In a recent issue of Current Biology, Schiebel and coworkers reveal that cell-cycle regulatory kinases and a phosphatase tightly regulate the centrosome duplication cycle by targeting Sfi1, a structural component of the yeast centrosome [5] . The direct link between the cell cycle and the centrosome cycle has spurred studies examining whether key cell cycle regulators, including cyclin-dependent kinases (CDKs), Polo-like kinases and separase, also play roles in the centrosome cycle [6] [7] [8] [9] . Together, these findings have revealed that centrosome duplication is 'licensed' once per cell cycle. The concept of licensing was originally introduced through studies of DNA replication where the key licensing step is the loading of pre-replicative complexes prior to the unwinding of double-strand DNA [10] . In the context of centrosomes, licensing involves the process of centriole 'disengagement', an event where two orthogonally placed centrioles becomes detached in late mitosis [11] . A protease called separase, which becomes active in anaphase, is required for disengagement, and the loosened centrioles are expected to expose the site of duplication for the next round of duplication [9] .
More direct involvement of structural component(s) of the centrosome in the licensing process was proposed by Kilmartin and colleagues based on elegant studies of spindle pole bodies (SPBs), the centrosome equivalent in budding yeast [12, 13] . Sfi1 is a filamentous molecule found at the 'half-bridge' of the SPB [12, 13] . The half-bridge is a structure associated with the core SPB and in the duplicated SPBs two core SPBs are connected by an extended (full) half-bridge [14, 15] ( Figure 1 ). Strikingly, in the duplicated SPBs, the carboxyl terminus of Sfi1 is in the middle of the extended half-bridge while the amino terminus of Sfi1 is proximal to the core SPBs [12, 13] . In the unduplicated SPB, the Sfi1 carboxyl terminus appears in electron micrographs to lie exposed to the cytoplasm. The authors interpreted this to mean that Sfi1 molecules dimerise through end-on interaction of their caroboxyl termini in duplicated SPBs, either with the help of additional SPB components or not. Based on this Sfi1 geometry, the authors proposed that the duplication process starts in early G1 with the Sfi1 carboxyl terminus present at the mother SPB, associating with the carboxyl terminus of a new Sfi1 molecule whose free amino terminus then attracts core SPB components to complete the process [12] . Hence, the carboxyl terminus of Sfi1 acts as a 'template' for the daughter SPB. When the template is being used and occupied, another round of duplication is inhibited. In this manner, only a single copy of the SPB is produced during one cell cycle [12] . In their model, post-translational modification of the carboxyl terminus of Sfi1 and/or proteins interacting with it could play a crucial role in SPB duplication, thereby providing a potential licensing mechanism. The work also suggests an essential requirement of such template molecules: they need to be geometrically located at the centre of the symmetric half-bridge structure of the duplicated SPBs/centrosomes [16] .
Strong support for this hypothesis came from isolation of four sfi1 alleles that show synthetic lethality with mad1D [17] , where spindle assembly checkpoint (SAC) is compromised; thus, the identified sfi1 mutants were expected to affect the process of bipolar spindle formation. All four alleles were found to harbour mutations in the carboxy-terminal region of Sif1 and are deficient in separation of the duplicated SPBs. Furthermore, overexpression of Cin8p, a plus-end-directed kinesin motor required to establish a bipolar spindle that pushes the duplicated SPBs away, partially rescues the phenotype. These observations beautifully fit with the hypothesis that a cell cycle-dependent regulation occurs at the carboxyl terminus of Sfi1 to mediate separation of the duplicated SPB. However, neither the modification status of Sfi1 nor enzymes responsible for any such modification had been identified.
In the recent issue, Schiebel and coworkers explore the modification status of Sfi1 and present direct evidence that phosphorylation of the carboxyl terminus determines the licensing status of SPB duplication [5] . They first identified six residues phosphorylated by Cdk1. Interestingly, all six residues were found in the carboxyl terminus of Sfi1. The physiological significance of the phosphorylation was assessed by mutating all of the residues into non-phosphorylatable alanine (sfi1 Cdk1 -6A), or phosphomimetic aspartic acid (sfi1 Cdk1 -6D). Both alleles were lethal in a dominant negative manner, underlining the importance of accurately regulating the Sfi1 phosphorylation.
Observation of the SPB duplication status of these mutants revealed striking phenotypes: while sfi1
Cdk1 -6A results in duplicated but non-separable SPBs that failed to establish a bipolar mitotic spindle, unduplicated SPBs were found in the cells harboring sfi1
Cdk1 -6D. Interestingly, the sfi1 Cdk1 -6A mutant did not result in SPB overduplication. This may reflect the prediction that once the template site is occupied, additional rounds of duplication are inhibited.
The authors also observed a similar, but somewhat weaker, effect of Sfi1 phosphorylation by the polo-like kinase, Cdc5. Three major Cdc5 phosphorylation sites were identified in the Sfi1 carboxyl terminus and were mutated to aspartic acid to generate a G1 S G2 M Start P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P P sfi1 Cdc5 -3D allele, which produced a single unduplicated SPB in about 30% of cells. An sfi1
Cdc5 -3A did not show a detectable phenotype. From these observations, the authors hypothesise that in G1 phase of the cell cycle, both CDK and Cdc5 activities are low and non-phosphorylated Sfi1 molecules form dimers through interactions between their carboxyl termini as the first step of SPB duplication. Separation of the duplicated SPB is then directed by Cdk1 as its activity rises in S-G2 phase, while further phosphorylation by Cdc5 at M phase generates a hyper-phosphorylated form of Sfi1 that prevents overduplication.
To complete the SPB duplication cycle, one would predict the reversal of these phosphorylation events as cells re-enter G1. Based on this prediction, the authors explored whether the Cdc14 phosphatase, which becomes active in late anaphase, participates in the SPB duplication cycle. When Cdc14 was inactivated in cells exiting mitosis, they failed to duplicate the SPB in the following cell cycle, thus revealing Cdc14 as an essential regulator of SPB duplication. An in vitro phosphatase assay confirmed that Cdc14 is capable of removing phosphates added to Sfi1 by Cdk1. Collectively, the authors propose that the SPB duplication cycle is regulated through phosphorylation at the Sfi1 carboxyl terminus mediated by well known cell cycle regulators (Figure 1) . In summary, when Sfi1 is dephosphorylated, the SPB duplicates through dimerization of the Sfi1 carboxyl terminus followed by assembly of the core SPB at the Sfi1 amino terminus. The duplicated SPBs are then separated upon phosphorylation by Cdk1 and Cdc5, leading to bipolar spindle formation. At the end of mitosis, Cdc14 dephosphorylates the Sfi1 carboxyl terminus, allowing to it to act as a duplication template once more.
These results provide highly persuasive evidence that licensing of SPB duplication is achieved through direct modification of a structural SPB component. Moreover, this study helps us to understand the step-by-step molecular mechanism of SPB duplication. Intriguingly, despite the apparent morphological differences between yeast SPBs and higher eukaryote centrosomes, a comparable process may be applicable to centrosome duplication. In Caenorhabditis elegans, ZYG-1, a functional homologue of the polo-like kinase Plk4, phosphorylates SAS-6, a structural component of the centriole, to promote daughter centriole formation [18] .
The authors also observed that dephosphorylation of Sfi1 by Cdc14 is not sufficient to prime SPB duplication. A kinase called Mps1 is also required to recruit Sfi1 to the mother SPB during G1, as the first step of the duplication. This result supports the previous studies that Mps1 is required for multiple steps of SPB duplication, including half-bridge extension [19, 20] . As Mps1 phosphorylates multiple SPB proteins, including Cdc31 and Kar1, both of which are half-bridge components [20] , its mode of action in G1 is likely to be beyond mere modification of the Sfi1 carboxyl terminus. An interesting possibility may be that Mps1 phophorylates Cdc31, a binding partner of Sfi1, to alter Sfi1 structure. One Sfi1 molecule is estimated to directly bind to about 20 molecules of Cdc31, a centrin-like molecule, and hence Cdc31 is expected to modulate the molecular conformation of Sfi1 [12] . Therefore, Mps1 may phosphorylate Cdc31, causing the Sfi1 carboxyl terminus, which has been already dephosphorylated by Cdc14, to become exposed for the next round of SPB duplication. In other words, Mps1 may bring about the conformational change of the SPB, equivalent to the action of separase in centriole disengagement.
To fully understand the role of Sfi1 in the SPB duplication cycle, it will be necessary to investigate how phosphorylation status affects the structural properties of an Sfi1 molecule. Whether Sfi1 orthologues have similar roles in centrosome duplication in higher eukaryotes is another obvious question to be addressed in future.
